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Abstract The insertion sequence IS6110 is frequently used
as a marker for the presence of ancient DNA (aDNA) de-
rived from bacteria of the Mycobacterium tuberculosis
complex (MTBC) in human archaeological remains. The
specificity of polymerase chain reactions (PCRs) directed
at IS6110 has, however, been questioned, because iden-
tical or similar elements have been identified in myco-
bacteria other than tuberculosis (MOTT). These are
Mycobacterium species, common in the environment, which may occasionally cause opportunistic diseases and are
not normally associated with clinical cases of tuberculosis (TB). We report the presence of two sequence types that
are similar, but not identical, to IS6110 in bone samples from nine skeletons dated mainly to the Roman period, one
from Scotland and the others from the remainder of Britain. The sources of these sequences cannot be established but
they are most likely derived from environmental bacteria that have colonised the skeletons after death. The data
presented support the notion that IS6110 may not be unique to the members of the MTBC and is, therefore, not
suitable as a specific marker for the identification of TB in human remains.
Statement of significance Individuals who suffered from tuberculosis in the past can sometimes be identified by
examining archaeological skeletons for the presence of DNA from the bacteria that cause the disease. Often the
DNA that is searched for is a sequence called IS6110, which is thought to be present only in the Mycobacterium
tuberculosis family of bacteria. If the IS6110 sequence is detected in a bone or tooth then that individual must have
been infected with tuberculosis bacteria. This test has been used frequently since the 1990s to identify tuberculosis
in archaeological remains, but we show that it is not accurate. Sequences similar to IS6110 are also present in other
bacteria, including ones that live in soil and which might get into a bone or tooth while the skeleton is buried. The
IS6110 test should not therefore be used to detect archaeological tuberculosis unless accompanied by other tests
that are more specific.
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Introduction
Authentication of results is a critical aspect of ancient
DNA (aDNA) research. When working with human
aDNA, the most pressing concern is the possibility
that samples are contaminated with modern DNA
from people who come in contact with the material
during excavation and post-excavation processing,
and from polymerase chain reaction (PCR) products
that have been allowed to contaminate reagents,
plasticwares or the clothing of laboratory personnel
(Gilbert et al. 2005; Yang and Watt 2005; Pilli et al.
2013). Several publications have addressed the
technical regime needed to prevent modern human
contamination and to recognise it when it occurs
(Cooper and Poinar, 2000; Hofreiter et al. 2001; Pääbo
et al. 2004). Human skeletons can also be sources of
pathogen aDNA, enabling diseases, such as tubercu-
losis (TB), to be studied. Contamination with modern
DNA, especially PCR products, from the pathogen of
interest is an equally important issue in palaeomi-
crobiological research (Roberts and Ingham 2008),
but it is not the only problem that arises. It is also
likely that samples will be contaminated with DNA
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from the microbiome of the individual whose
remains are being analysed and/or from environ-
mental bacteria that have colonised the skeleton
after death (Wilbur et al. 2009; Tsangaras and
Greenwood 2012). The presence of this type of
contaminating DNA will confuse the detection of
pathogen aDNA if markers that are thought to be
speciﬁc for the pathogen are in fact present in the
contaminating species also. This is possible in many
cases where the PCR for a pathogen is designed to
be speciﬁc in a clinical setting, for use with samples
that are unlikely to be contaminated with environ-
mental species (Wilbur et al. 2009). The use of this
PCR on archaeological samples might then give rise
to false-positives. The extent to which this is a pro-
blem has not been tested, but it could be a signiﬁ-
cant issue bearing in mind that the number of
bacterial species on the planet is unknown and the
characterised species probably only represent a
minor percentage of the total (Whitman et al. 1998;
Curtis et al. 2002).
Past research on ancient TB illustrates the potential
complications caused by bacterial contamination of
archaeological extracts. The ﬁrst aDNA study of TB
used PCR to amplify a 123 bp segment of an insertion
sequence called IS6110 (Spigelman and Lemma 1993).
This insertion sequence was thought to be speciﬁc to
the causative agents of TB in human beings and
animals, the members of the Mycobacterium tubercu-
losis complex (MTBC) (Eisenach et al. 1990), which
comprises M. tuberculosis, Mycobacterium bovis,
Mycobacterium africanum, Mycobacterium canettii,
Mycobacterium microti, Mycobacterium pinnipedii and
Mycobacterium caprae. IS6110 is still the most fre-
quently used target for detection of MTBC aDNA, as it
can be present in up to 25 copies/cell (Brosch et al.
2000), enhancing the likelihood that it will be detected
in ancient remains. However, it is clear that similar
sequences are present in mycobacteria other than
tuberculosis (MOTT). This was ﬁrst shown by Eisenach
et al. (1990), who used the standard IS6110 PCR and
obtained an ampliﬁcation product of the expected size
with a Mycobacterium simiae strain. They did not
conﬁrm that this product was derived from IS6110 and
did not consider the result to be particularly import-
ant, as the presence of the element in M. simiae would
have little impact on MTBC research, M. simiae being a
rather uncommon isolate in clinical samples. More
recent studies have further investigated the occur-
rence of IS6110 within the genus Mycobacterium.
Some reports attributed ampliﬁcation of IS6110 from
MOTT to false-positives arising from sample cross-
contamination or contaminated reagents (Clarridge
et al. 1993; Noordhoek et al. 1994), but others continue
to question the speciﬁcity of IS6110 PCRs (Kent et al.
1995; Liébana et al. 1996; McHugh et al. 1997; Bhanu
et al. 2004; Coros et al. 2008; Thacker et al. 2011).
Ampliﬁcation of a sequence identical to IS6110 has
been reported for a Mycobacterium wolinskyi strain
(Thacker et al. 2011), and sequences with similarity to
IS6110 have been found in two Mycobacterium for-
tuitum strains (Bhanu et al. 2004) and Mycobacterium
smegmatis. In the latter species, the coding region
showed 67% amino acid identity with IS6110 from
MTBC (Coros et al. 2008).
The ongoing debate about the speciﬁcity of IS6110
is particularly important for aDNA studies. Often
reports of IS6110 aDNA detection, and hence of TB
presence, are based solely or in part on amplicon size
before (Taylor et al. 1996; Gernaey et al. 2001; Mays
et al. 2002) or after restriction enzyme digestion (Haas
et al. 2000; Zink et al. 2001; Konomi et al. 2002). These
approaches are clearly prone to misinterpretation as
they do not even establish that the nucleotide
sequence of the amplicon is identical to that of IS6110
from MTBC. Here, we show that some archaeological
samples do indeed contain IS6110-like elements that
give ampliﬁcation products of the expected size when
the standard PCR (Eisenach et al. 1990) is used, but
Table 1 Samples
Sample*
Age
(centuries)
Elements showing possible
TB lesions
Sampled
from
MTBC
aDNA
status†
IS6110-like
sequence
type
3 Driffield Terrace 13 Late 2nd–early 3rd AD Ribs, mandible, femora, metatarsals Rib D A
Ashchurch 705 129–317 calAD Ribs Rib A A
Auldhame 43 1280–1394 calAD Ribs Rib A A
Easington/Ganstead 25183 2nd AD Vertebrae Vertebra D A
Horncastle 6 136–335 calAD None Tibia D B
Horncastle 7‡ 3rd AD None Long bone D B
Horncastle 20 3rd AD None Radius B B
Kempston 3902 3rd–4th AD None Femur C A
Weston-super-Mare 01 Roman Vertebrae, humerus Vertebra D B
*All samples are from Roman sites in England except for the mediaeval sample from Auldhame (Scotland).
† According to the criteria described by M €uller et al. (2014): A, ‘definitely’ containing MTBC aDNA (cloned amplicon sequences from
at least two extracts matched the 123 and/or 92bp reference for IS6110); B, ‘probably’ containing MTBC aDNA (cloned amplicon
sequences from one of duplicate or multiple extracts matched the 123 and/or 92bp reference for IS6110); C, ‘possibly’ containing
MTBC aDNA (at least one extract gave a positive result with an IS1081 qPCR); D, no evidence of MTBC aDNA (negative results for
IS6110 PCRs and IS1081 qPCRs).
‡ Horncastle 7 is not described by M €uller et al. (2014) but was tested independently.
aDNA: ancient DNA; TB: tuberculosis; PCR: polymerase chain reaction; MTBC: Mycobacterium tuberculosis complex.
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which have sequence differences compared with
IS6110 of MTBC.
Methods
The results reported here relate to bone samples
from nine skeletons dating to the ﬁrst to fourteenth
centuries AD, from seven sites in Britain (Table 1).
Five of these skeletons displayed pathological
alterations possibly suggesting infection with MTBC.
Eight of the nine skeletons were included in a larger
survey in which the degree of reproducibility and
authenticity of PCRs directed at the IS6110 and
IS1081 sequences was used to determine the like-
lihood that an individual sample contained MTBC
aDNA (Müller et al. 2014). Using the criteria descri-
bed in that paper, two of these nine samples were
identiﬁed as ‘deﬁnitely’ containing MTBC aDNA,
one to ‘probably’ contain MTBC aDNA, and one to
‘possibly’ contain MTBC aDNA (Table 1). For the
other ﬁve samples, there was no evidence of MTBC
presence.
All samples were taken under clean conditions
using either a hacksaw or an electronic drill by per-
sonnel wearing a forensic suit, face mask, hair net and
gloves. Sampling tools were cleaned with DNA Away
(Molecular BioProducts, San Diego, USA) between
each sampling. Until their preparation, all samples
were stored in separate bags under dry conditions. All
pre-PCR steps were carried out in two independent,
physically isolated laboratories each ﬁtted with ultra-
ﬁltered air supply maintaining positive displacement
pressure. DNA extractions were performed in a Class II
biological safety cabinet in one laboratory, and PCRs
were set up in a laminar ﬂow cabinet in the second
laboratory. All surfaces within the laboratories were
regularly ultraviolet (UV) irradiated and cleaned with
5% bleach and 70% ethanol. Equipment was treated
with DNA Away before and after use and items such as
tubes, pipettes and aqueous solutions were UV irra-
diated in a Stratalinker (254 nm, 120 000 μJ cm22 for at
least 2 £ 5min, with 180° rotation between the two
exposures and 5–10 cm between sample and UV
source) before use. The laboratory personnel wore
forensic suits, face masks, hair nets, goggles and two
pairs of sterile gloves at all times.
Preparation of samples was carried out by removing
approximately 1–2mm of the outer surface of the
bones mechanically with a scalpel. In cases where
cancellous bone was obviously inﬁltrated by soil or
had been exposed to the environment, the cancellous
bone was also removed. After subsequent bilateral UV-
irradiation (conditions as above) for 5min, each bone
was put into a DNA-free plastic bag, crushed into
powder and 250mg bone powder was used for DNA
extraction.
DNA extractions were performed by one of the two
silica-based methods described previously by Bouw-
man and Brown (2005) and Bouwman et al. (2012).
Polymerase chain reactions were set up in 30 μl reac-
tions containing 2.5–5.0 μl DNA extract, 1 £ AmpliTaq
Gold PCR Master Mix (Applied Biosystems, Warrington,
UK), 400 nM each primer, 1% BSA and ultrapure water.
First-round PCRs (primers: 5ʹ-CCTGCGAGCGTAGGCG-
TCGG-3ʹ, 5ʹ-CTCGTCCAGCGCCGCTTCGG-3ʹ; Eisenach
et al. 1990) were run for one cycle for 7min at 95°C,
followed by 45 cycles each consisting of 1min at 68°C,
1min at 72°C and 1min at 94°C, with a ﬁnal extension
for 10min at 72°C. Nested PCR was performed after
repetition of the ﬁrst-round PCR with 35 cycles instead
of 45 cycles. The nested PCR used 1 μl of ﬁrst-round
product and was set up as described above but with a
different set of primers (5ʹ-TCGGTGACAAAGGCCA-
CGTA-3ʹ, 5ʹ-TTCGGACCACCAGCACCT-3ʹ; Taylor et al.
1996) and with 25 cycles at an annealing temperature
of 58°C. Ampliﬁcation products were run on a 2%
agarose gel and puriﬁed products cloned into Escher-
ichia coli XL1-Blue competent cells (Agilent, Stockport,
UK) using the CloneJet PCR cloning kit (Thermo Fisher
Scientiﬁc, Altrincham, UK). Clones were sequenced
Figure 1 Alignment of sample sequences to the IS6110 sequence of Mycobacterium tuberculosis H37Rv
(GenBank accession number: NC_000962.3). Primers are removed. Differences to the reference sequence are
highlighted in colours. Letters a–j indicate the respective cloning sequence for a sample. Only one cloning
sequence was available for Auldhame 43 and Horncastle 7 and the amplicon of Easington/Ganstead 25183 was
directly sequenced
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(GATC Biotech, Cologne, Germany) and aligned with
an IS6110 reference sequence using Geneious version
7. 1. 7 (available from: http://www.geneious.com/).
A direct sequence was also obtained for the IS6110
amplicon from the Easington/Ganstead 25183 sample.
BLAST (Altschul et al. 1990) was used to compare
sequences with the GenBank database (Benson et al.
2006). Novel sequences obtained in this study have
been deposited in the European Nucleotide Archive
(accession numbers LN678636-LN678637).
Results
The authors had previously surveyed the presence of
MTBC aDNA in samples from skeletons from a wide
range of archaeological sites from different time
periods (Müller et al. 2014). During this project, they
identiﬁed nine samples that gave ambiguous results
for PCRs directed at IS6110. These nine samples (Table
1) gave a product of approximately 123 bp after the
ﬁrst-round PCR, suggesting that they may contain
MTBC aDNA. However, all apart from one sample
(Auldhame 43) failed to give the 92 bp product
expected after the nested PCR. The sequences
obtained from the cloned ﬁrst-round products, as well
as a direct sequence of one sample (Easington/Gan-
stead 25183), revealed two main sequence types,
A and B, both of which had 16 nucleotide differences
compared with the IS6110 reference, 11 of these
positions are common to both A and B (Fig. 1).
Sequence A was obtained from 3 Drifﬁeld Terrace 13,
Ashchurch 705, Auldhame 43, Easington/Ganstead
25183 and Kempston 3902, and sequence type B from
Horncastle 6, Horncastle 7, Horncastle 20 and Weston-
super-Mare 01. Most of the clone sequences exactly
matched one or the other of the sequence types, but
there were a few individual variations. Horncastle
clones 6-a and 6-b were both of sequence type B, but
6-b had a G! T transversion at position 66. This
transversion was also present in the single clone for
Horncastle 7, which additionally had a nucleotide
change at position 1. Further single changes were
seen in single clones obtained for Ashchurch 705 and
Horncastle 20. BLAST searches of the ampliﬁed pro-
ducts with the primers removed identiﬁed IS6110 of
MTBC as a similar sequence to types A and B in Gen-
bank, but also gave high scores to sequences of other
genera of Actinobacteria, such as Nocardia, Micro-
monospora, Geodermatophilus and to the genus Tis-
trella of Proteobacteria (Table 2). Additionally, more
distant similarity to several MOTT species was found,
to Mycobacterium sp. JLS and M. smegmatis for
sequence type A and Mycobacterium sp. JLS, Myco-
bacterium marinum, M. smegmatis, Mycobacterium
intracellulare, Mycobacterium gilvum, Mycobacterium
chubuense, Mycobacterium sp. KMS and Mycobacterium
sp. MCS for sequence type B (Table 2). Most of these
BLAST hits encompass sequences which encode for
transposases, enzymes with the same function as that
encoded by the ampliﬁed part of IS6110. None of the
sequence variations that the authors identiﬁed affect
the integrity of the transposase open reading frame,
either being silent or resulting in a conservative sub-
stitution. Alignment with the consensus sequences for
the IS6110 type A and B variants revealed that each of
the BLAST hits from species other than MTBC had
mismatches in the primer annealing sites (Fig. 2). From
the distribution of the mismatches, it is possible that at
least some of these priming sites could direct ampli-
ﬁcation, in particular if the extract contains relatively
little competing target DNA (i.e. canonical IS6110
sequences), and if a high number of PCR cycles are
used, as is commonplace when a DNA extracts are
being ampliﬁed. Nevertheless, the reported BLAST hits
only provide an indication as to the possible origins of
the type A and B sequences.
Discussion
Using a PCR that is looked on as speciﬁc for the
MTBC insertion sequence IS6110, we obtained
amplicons of the expected size but of unknown
origin from nine archaeological skeletons. These
sequences are similar to the IS6110 of MTBC but
contained 16 nucleotide differences in the 123 bp
sequence, the same differences found consistently in
Figure 2 Alignment of consensus IS6110-like sequence types A and B to the corresponding sequences
revealed by BLAST search (Table 2). Primer binding sites are framed in black. Differences to sequence types A
and B are highlighted in colours
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different samples and hence unlikely to represent
damage-derived DNA miscoding lesions or PCR
error-induced changes (Gilbert et al. 2003, 2007;
Brotherton et al. 2007). It has been recently
suggested that some IS6110 sequence heterogeneity
exists in the MTBC (Sankar et al. 2011) but the
changes we report have never been reported in
clinical MTBC. Although we cannot exclude the
possibility that these sequences were present in
ancient varieties of the MTBC, this seems rather
unlikely. Instead, we suggest that these sequences
come from one of the following sources: (1) bacteria
present in the burial and/or storage environment
that colonised the skeletal elements at some stage
after burial; (2) ancient nonpathogenic bacteria from
the individual's microbiome; or (3) ancient patho-
genic bacteria that the individual was infected with
during life. Analysis of material associated with the
burial environment of skeletons containing IS6110-
like sequences, such as soil samples or co-located
animal bones, may therefore be useful for estab-
lishing their origin.
The value of IS6110 as a marker for TB has repeat-
edly been scrutinised since this element was ﬁrst
suggested as being unique to the members of the
MTBC. The original description of the standard PCR for
IS6110, amplifying a 123 bp fragment and commonly
used in aDNA studies of TB, also reported detection of
IS6110 in a M. simiae strain (Eisenach et al. 1990). This
Mycobacterium, although occasionally incorrectly
referenced (Konomi et al. 2002; Lalremruata et al.
2013), is not a member of the MTBC, and the original
paper recommended that further studies need to be
carried out to corroborate the unique presence of
IS6110 in the MTBC. Several studies have subsequently
reported ampliﬁcation of sequences from MOTT
species by PCRs designed for IS6110 detection (Clar-
ridge et al. 1993; Noordhoek et al. 1994; Kent et al.
1995; Liébana et al. 1996; McHugh et al. 1997; Bhanu
et al. 2004; Coros et al. 2008; Thacker et al. 2011). For
example, Thacker et al. (2011) obtained ampliﬁcation
products from several MOTT species with the IS6110
PCRs described by Eisenach et al. (1990) and Plikaytis
et al. (1991). Although the design of a more speciﬁc
real-time PCR assay improved their results, an ampli-
ﬁcation signal was still obtained for a M. wolinskyi
strain. This prompted Thacker et al. to sequence a
317 bp amplicon obtained by conventional PCR,
revealing sequence identity between the M. wolinskyi
strain and M. bovis. These, as well as our own ﬁndings,
suggest that PCRs that target the 123 bp sequence
reported by Eisenach et al. (1990), or other parts of
IS6110, are not speciﬁc for the detection of MTBC,
especially when dealing with samples that may con-
tain a variety of mycobacteria and/or related species
as is the case with environmental or archaeological
material.
Further work is needed to establish which species
gave rise to our IS6110-like detections reported here,
and whether these are mycobacteria or members of
other genera. Most of the mycobacteria identiﬁed to
date are either environmental saprophytes or
opportunistic pathogens (Kazda 2009). The members
of the MTBC, however, are obligate pathogens
causing pulmonary and/or extra-pulmonary disease.
Tuberculosis can affect the skeleton and occasionally
leaves lesions that can be recognised in archae-
ological remains (Jaffe 1972; Ortner 2003; Roberts
and Buikstra 2003), as displayed by ﬁve of the nine
individuals from which the authors obtained non-
speciﬁc IS6110 results. It is, of course, quite possible
for a skeleton to contain both MTBC aDNA and
environmental DNA, and if the latter predominates,
then the presence of genuine IS6110 amplicons
might only be revealed by deeper sequencing than
we have carried out in this project. However,
opportunistic MOTT, such as Mycobacterium avium,
M. intracellulare, Mycobacterium haemophilum,
M. marinum, M. fortuitum, Mycobacterium abscessus
and Mycobacterium kansasii, have also been reported
occasionally to give rise to skeletal lesions similar to
those caused by TB (Hirsch et al. 1996; Theodorou
et al. 2001; Elsayed and Read 2006; Shimizu et al.
2013). It is, therefore, possible that some skeletons
displaying pathological alterations associated with
TB result from infection with MOTT species, rather
than the MTBC.
It has been argued that MTBC aDNA may survive
better than human aDNA, as a result of the charac-
teristics of the mycobacterial cell wall and the high GC
content of the mycobacterial DNA (Zink et al. 2002;
Donoghue et al. 2004). These characteristics are not
restricted to the MTBC and are shared by MOTT
species; so, if there is preferential survival of myco-
bacterial aDNA, then this will apply to contaminating
species and not just the MTBC. The results presented
here illustrate the extent to which this might be a
problem affecting TB aDNA studies. The nine samples
that we report here, each of which gave non-authentic
IS6110 detections, came from an original set of
78 samples. Most of these 78 samples displayed
lesions suggestive of TB, and 22 gave genuine IS6110
PCR products, as checked by sequencing. Nine false-
positives, therefore, represent an error rate of 11.5%
when the set as a whole is considered, or 29% when
those giving IS6110 PCR products are considered.
Hence, there is a substantial risk of misidentiﬁcations
of TB in the archaeological record when using aDNA
analysis if the outcomes of these PCRs are not ana-
lysed properly. Presence of products of the correct size
on an agarose gel is clearly an inadequate test.
Restriction analysis of PCR products also runs the risk
of giving misleading results. In some studies (Haas
et al. 2000; Zink et al. 2001), the product has been
tested by HaeIII digestion, which gives 29 and 94 bp
products from the 123 bp MTBC IS6110 amplicon. The
banding pattern for these fragments on an agarose gel
would be difﬁcult to distinguish from 21 and 102 bp
fragments that HaeIII digestion would give from our
non-authentic sequence type A. There might even be
Mu¨ller et al. Complications in the study of ancient tuberculosis STAR2014112054892314Y.0000000002
6 Science and Technology of Archaeological Research 2015 VOL 1 NO 1
confusion with the 21, 28 and 74 bp fragments yielded
by sequence type B. It is clear that the only unam-
biguous method of conﬁrming the authenticity of an
IS6110 PCR is to fully sequence the product. Even then,
detection of MTBC cannot be assumed. If, as we have
shown, related sequences are present in MOTT or
other bacterial species, then it cannot be assumed that
identical sequences are not present in MOTT or other
bacterial species also.
Conclusion
Our discovery of unknown IS6110-like sequences in
nine archaeological samples, along with the previous
reports of IS6110-like sequences in MOTT species,
forces a re-evaluation of the use of IS6110 in the
detection of MTBC aDNA. Detection of IS6110 should
not be looked on as evidence for the presence of
MTBC aDNA, unless supported by ampliﬁcation and
sequencing of other genomic regions. The opportunity
for non-speciﬁc ampliﬁcation is substantial, as indi-
cated by the false-positive error rate of 11.5% that was
obtained in the survey of 78 samples for IS6110.
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